InsidersTradesSigma
Discover the full record of transactions filed by Alsakali Equity AB. Director active across 2 companies, notably Newbury Pharmaceuticals AB. Aggregated, 2 filings have been logged. The latest transaction was disclosed on 18 November 2025 — Purchase. Regulator: FIN-FSA. All data is openly available.
2 of 2 declarations